
51 - 200 funcionários
Fundada em 2016
🏥 Saúde
💼 Consultoria
⚖️ Jurídico
Healthcare • Consulting • Legal
A Immunic Therapeutics é uma empresa de biotecnologia em estágio avançado, focada no desenvolvimento de novas terapias de moléculas pequenas, administradas por via oral, para doenças inflamatórias crônicas e autoimunes, com programas específicos direcionados à esclerose múltipla e doença celíaca. A empresa avança com programas diferenciados em estágio clínico (ex. : vidofludimus calcium, IMU-856, IMU-381) visando fornecer opções de tratamento oral eficazes, seguras e bem toleradas para condições neurológicas e gastrointestinais mediadas pelo sistema imunológico, enquanto busca proteções regulatórias e caminhos para comercialização.
🕒 Julho 29
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

51 - 200 funcionários
Fundada em 2016
🏥 Saúde
💼 Consultoria
⚖️ Jurídico
Healthcare • Consulting • Legal
A Immunic Therapeutics é uma empresa de biotecnologia em estágio avançado, focada no desenvolvimento de novas terapias de moléculas pequenas, administradas por via oral, para doenças inflamatórias crônicas e autoimunes, com programas específicos direcionados à esclerose múltipla e doença celíaca. A empresa avança com programas diferenciados em estágio clínico (ex. : vidofludimus calcium, IMU-856, IMU-381) visando fornecer opções de tratamento oral eficazes, seguras e bem toleradas para condições neurológicas e gastrointestinais mediadas pelo sistema imunológico, enquanto busca proteções regulatórias e caminhos para comercialização.
• Lead U.S. Market Access strategy and organization build for vidofludimus calcium's launch, covering pricing, contracting, reimbursement, and distribution • Develop integrated access strategies spanning Commercial, Medicare, Medicaid, VA, DoD, and other government channels • Own national payer strategy, negotiating with health plans, PBMs, IDNs, health systems, and specialty pharmacies • Build payer value propositions using clinical, economic, and real-world evidence to drive favorable formulary coverage • Set pricing strategy, gross-to-net assumptions, and specialty pharmacy/trade/distribution frameworks, ensuring launch-ready operations • Partner with Medical Affairs/HEOR on payer evidence strategy, AMCP dossiers, and value communication; support post-launch evidence generation • Serve on Commercial Leadership Team, coordinating with Marketing, Sales, Medical, Regulatory, Finance, Legal, and Supply Chain on launch readiness • Design and build the Market Access org structure, capabilities, and metrics across Payer Strategy, Marketing, Pricing/Contracting, Trade, Analytics, and Excellence functions • Recruit and lead a field Market Access team: National, Federal, and Regional Account Managers plus Field Reimbursement Managers • Set field deployment strategy (territories, hiring, training, incentives) and ensure tight collaboration with Sales and Medical Affairs to maximize adoption
• Bachelor's degree required; MBA, PharmD, MPH, or other advanced degree preferred. • 15+ years of progressive leadership experience within the pharmaceutical or biotechnology industry. • Demonstrated success leading U.S. Market Access organizations for specialty pharmaceutical products. • Direct experience leading the U.S. Market Access strategy for one or more multiple sclerosis product launches is strongly preferred. • Candidates who have played a significant leadership role in the commercialization of successful MS therapies will be strongly favored. • Deep understanding of the competitive dynamics, payer landscape, specialty pharmacy networks, treatment centers, and reimbursement environment within multiple sclerosis as well as negotiating with commercial payers, PBMs, Medicare Part D plans, federal healthcare systems, specialty pharmacies, and integrated health systems. • Demonstrated success building and leading field-based Market Access organizations; experience building commercial infrastructure within an emerging biotechnology company or first-launch organization strongly preferred.
• Health insurance • 401(k) • Paid time off • Flexible working arrangements • Professional development opportunities
Candidatar-se🕒 Julho 29
Group Vice President leading a team to drive operational excellence and strategic growth in veterinary healthcare. Overseeing P&L performance and fostering a collaborative team culture.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $196.000 - $235.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 29
Group Vice President leading a team of Regional Operations Directors to enhance veterinary medicine and hospital performance. Responsible for strategic growth, operational excellence, and people-first leadership.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $196.000 - $240.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 29
VP of Marketing leading Ditto's marketing strategy and execution, a company redefining data connectivity. Collaborating with sales and product teams to build brand awareness and drive pipeline.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $288.000 - $300.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 29
Executive Benefits RVP driving premium growth and expanding market presence for John Hancock’s Executive Benefits solutions. Leading business development and consultative sales efforts across the Western US territory.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $70.000 - $121.300 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Julho 29
Regional Vice President overseeing Mid-Large Market retirement sales for Manulife John Hancock across the Pacific. Leading strategy, relationships, and consultative sales in a competitive retirement landscape.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $100.000 - $175.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório